IRIS Accounts Production v26.1.0.640 06318977 director 1.10.24 30.9.25 30.9.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063189772024-09-30063189772025-09-30063189772024-10-012025-09-30063189772023-09-30063189772023-10-012024-09-30063189772024-09-3006318977ns15:EnglandWales2024-10-012025-09-3006318977ns14:PoundSterling2024-10-012025-09-3006318977ns10:Director12024-10-012025-09-3006318977ns10:PrivateLimitedCompanyLtd2024-10-012025-09-3006318977ns10:SmallEntities2024-10-012025-09-3006318977ns10:AuditExempt-NoAccountantsReport2024-10-012025-09-3006318977ns10:SmallCompaniesRegimeForDirectorsReport2024-10-012025-09-3006318977ns10:SmallCompaniesRegimeForAccounts2024-10-012025-09-3006318977ns10:FullAccounts2024-10-012025-09-3006318977ns10:CompanySecretary12024-10-012025-09-3006318977ns10:RegisteredOffice2024-10-012025-09-3006318977ns5:CurrentFinancialInstruments2025-09-3006318977ns5:CurrentFinancialInstruments2024-09-3006318977ns5:ShareCapital2025-09-3006318977ns5:ShareCapital2024-09-3006318977ns5:RetainedEarningsAccumulatedLosses2025-09-3006318977ns5:RetainedEarningsAccumulatedLosses2024-09-3006318977ns5:PlantMachinery2024-10-012025-09-3006318977ns5:FurnitureFittings2024-10-012025-09-3006318977ns5:ComputerEquipment2024-10-012025-09-3006318977ns5:PlantMachinery2024-09-3006318977ns5:FurnitureFittings2024-09-3006318977ns5:ComputerEquipment2024-09-3006318977ns5:PlantMachinery2025-09-3006318977ns5:FurnitureFittings2025-09-3006318977ns5:ComputerEquipment2025-09-3006318977ns5:PlantMachinery2024-09-3006318977ns5:FurnitureFittings2024-09-3006318977ns5:ComputerEquipment2024-09-3006318977ns5:WithinOneYearns5:CurrentFinancialInstruments2025-09-3006318977ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-30
REGISTERED NUMBER: 06318977 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025

FOR

ROSES MEDICAL LTD

ROSES MEDICAL LTD (REGISTERED NUMBER: 06318977)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 30 September 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ROSES MEDICAL LTD

COMPANY INFORMATION
for the Year Ended 30 September 2025







DIRECTOR: Mr T Cook





SECRETARY: Mrs J L Wright





REGISTERED OFFICE: 32 Booth Street
Booth Street Chambers
Ashton-Under-Lyne
Lancashire
OL6 7LQ





REGISTERED NUMBER: 06318977 (England and Wales)





ACCOUNTANTS: Moss and Williamson Limited
Chartered Accountants
11 Stamford Street
Stalybridge
Cheshire
SK15 1JP

ROSES MEDICAL LTD (REGISTERED NUMBER: 06318977)

BALANCE SHEET
30 September 2025

30.9.25 30.9.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 13,718 17,948

CURRENT ASSETS
Stocks 53,636 47,352
Debtors 6 23,875 172,511
77,511 219,863
CREDITORS
Amounts falling due within one year 7 153,277 212,591
NET CURRENT (LIABILITIES)/ASSETS (75,766 ) 7,272
TOTAL ASSETS LESS CURRENT
LIABILITIES

(62,048

)

25,220

PROVISIONS FOR LIABILITIES 2,606 3,410
NET (LIABILITIES)/ASSETS (64,654 ) 21,810

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (64,754 ) 21,710
SHAREHOLDERS' FUNDS (64,654 ) 21,810

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 May 2026 and were signed by:




Mr T Cook - Director


ROSES MEDICAL LTD (REGISTERED NUMBER: 06318977)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 30 September 2025

1. STATUTORY INFORMATION

Roses Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the net invoiced value of goods and services supplied excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Motor Vehicles - 25% on reducing balance
Equipment, fixtures & fittings - 20% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

ROSES MEDICAL LTD (REGISTERED NUMBER: 06318977)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 September 2025

3. ACCOUNTING POLICIES - continued

Going concern
The financial statements have been prepared on a going concern basis which assumes that adequate working capital is available to enable the company to continue trading beyond twelve months.. The director's intention is to continue to support the company in the long term and he is confident that its bankers will do likewise.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

5. TANGIBLE FIXED ASSETS
Equipment,
Motor fixtures Computer
Vehicles & fittings equipment Totals
£    £    £    £   
COST
At 1 October 2024
and 30 September 2025 48,450 35,280 11,354 95,084
DEPRECIATION
At 1 October 2024 37,322 30,102 9,712 77,136
Charge for year 2,783 1,036 411 4,230
At 30 September 2025 40,105 31,138 10,123 81,366
NET BOOK VALUE
At 30 September 2025 8,345 4,142 1,231 13,718
At 30 September 2024 11,128 5,178 1,642 17,948

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.25 30.9.24
£    £   
Trade debtors 21,463 166,134
Other debtors 2,412 6,377
23,875 172,511

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.25 30.9.24
£    £   
Bank loans and overdrafts 61,974 68,492
Trade creditors 28,983 49,280
Taxation and social security 3,157 3,267
Other creditors 59,163 91,552
153,277 212,591

8. RELATED PARTY DISCLOSURES

There were no material related party transactions requiring disclosure.

ROSES MEDICAL LTD (REGISTERED NUMBER: 06318977)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 September 2025

9. ULTIMATE CONTROLLING PARTY

Trevor Cook, the sole director controlled the company by virtue of holding the whole of the issued ordinary share capital.